CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in phase I clinical trial
The HEROS 2.0 trial showed that this therapeutic approach is safe and is associated with clinical benefit.
Read MoreThe HEROS 2.0 trial showed that this therapeutic approach is safe and is associated with clinical benefit.
Read MoreIn the vast landscape of cancer, sarcoma stands as a unique and complex disease. Unlike more well-known forms of cancer, such as breast or lung
Read MoreDr. E. Ramsay Camp with Baylor College of Medicine explains how sarcoma is diagnosed and effectively treated.
Read MoreOften dubbed the “forgotten cancer,” sarcoma is a rare cancer that impacts thousands of Americans every year. But what sets this disease apart from more
Read More